{"name":"Neogen Corporation","slug":"neogen","ticker":"NEOG","exchange":"NASDAQ","domain":"neogen.com","description":"Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and v","hq":"Lansing, MI","founded":0,"employees":"2974","ceo":"John Adent","sector":"Food & Animal Safety Diagnostics","stockPrice":10.45,"stockChange":0.47,"stockChangePercent":4.71,"marketCap":"$2.3B","metrics":{"revenue":900000000,"revenueGrowth":-2.8,"grossMargin":46,"rdSpend":21087000,"netIncome":-1092044000,"cash":129004000,"dividendYield":0,"peRatio":32.3,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"Neogen Corporation Reports Fourth Quarter and Fiscal Year 2023 Financial Results","summary":"Neogen Corporation reported fourth quarter and fiscal year 2023 financial results, with net sales of $173.4 million and $643.1 million, respectively.","drugName":"","sentiment":"neutral"},{"date":"2023-09-21","type":"deal","headline":"Neogen Corporation Acquires BioLumix","summary":"Neogen Corporation acquired BioLumix, a leading provider of rapid microbiological testing solutions for the food and animal safety industries.","drugName":"","sentiment":"positive"},{"date":"2023-06-15","type":"regulatory","headline":"Neogen Corporation Receives FDA Clearance for AccuPoint SARS-CoV-2 Test","summary":"Neogen Corporation received FDA clearance for its AccuPoint SARS-CoV-2 test, a rapid and accurate diagnostic solution for detecting COVID-19.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxNUkx1YWsyX085My1WTG5SV0RCY29VYWZ0SXJGeElVeDVHaVg5NzV6MGtxY090ZmZSX0pIVC10SktfdVFiQnJXcjktTWlVMVVpcXM3YnlYSkJRc1RKMU85UjVRUWdYY1ctWGxoNU9nWi02LXZzbzFOaGo4OFc3WmtZeGdlQW95Ui1GMFBKcU1RSEF2MTVwTGZzUWpuaV9yWGZacG56TzN1WFdXYk92VjFWSE0zSnhCN2hHcDRPcU5aaC1iemxrT2ZrODNEcTVRUktUVnlXNXhuZEJwVTlIYk5zYkNJVmtCeTU0dWRUcm15UHFHaDhfQ2RpVzlvNkpHRmR2MUp0ZzZxVQ?oc=5","date":"2026-04-08","type":"pipeline","source":"Business Wire","summary":"Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary - Business Wire","headline":"Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secreta","sentiment":"neutral"},{"date":"2026-03-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNcExYQ0o4UzA5d29ZTEJYMUhKV0owQ0liRXpsVWlUQW9MV3pzeVVROG9TdXR5dXMtb2hTdHJoM2hGTWZHRS1pcFFXQnlhTTdGUm5xM2lOcG43MkkwNnRFamNiRVJtX1l0RUZGRTUxazFtc2gtMnU4SjV4UjdIX1JyNkc3UkdxZmRGZjhndllzc0Y4eERrcGxVa19BaHlFTERIVV9OMjJka21jX2ZLNG53eFlB?oc=5","date":"2026-02-16","type":"pipeline","source":"Seeking Alpha","summary":"Neogen Corporation Could Re-Rate As 3M Food Safety Integration Improves (NASDAQ:NEOG) - Seeking Alpha","headline":"Neogen Corporation Could Re-Rate As 3M Food Safety Integration Improves (NASDAQ:NEOG)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQRjh4YUd0M245SWtBU3F3dTd1TE1tSTU5UldRSnFQQVZqYl9jcnU1Tnc2X0lGM25vc2N3SFg5Vkx1N3FtRXpOckpGUnFzSVBkcnk2MkU4QTJzWEF6TkFuSXRKUGdGVlhSc2RWZ2tkVmgwRlZhRkJ4MDQwMzVBb3BKSTQ0QlA5cktyX2M3dE9lWGZDUXBfZFUtOWhWZjAzdEt4MGNKQV9iQ2RXZzNHcV9TcVozMmtPUk9a?oc=5","date":"2026-01-28","type":"pipeline","source":"Stock Titan","summary":"Microbial contamination prompts Neogen recall of pet wound solution - Stock Titan","headline":"Microbial contamination prompts Neogen recall of pet wound solution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOVjhjZFdEd2VrX3NFT3k3YjFqc0tyZGJWdUxRUEhKa1pzZm9HaU16SlF4Q1FpcF9rR1pjSzJOTXhpTXNPa2pRMzhMOWk2T3lwOVlxUUkyZlBiX29LT3gyUE8yVDJKcFhINmZGcTktV2tqc3h0MHFzS04tajNDSUkxUEJwSzkyRlQ3Q0VnQ1Y3SmxSdGRXOVllN1FOWDlTUUluU2t6UWU3UE1CSlhjRFZzSnNjeTduaVcta2VoS1FXakdWZFQwM1EzOFRUTQ?oc=5","date":"2026-01-14","type":"pipeline","source":"Seeking Alpha","summary":"Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha","headline":"Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQdUdrVmtwZHZJZEw5ckQ5U3JNNDVWTFo4VHMtbmpneTBSaHZxcWo0eVNSUHBsaXZFX0VIOU43Tzg2TXJOSGFRUFcwTnhrWmtxNFNZNUJFTEFiVUJDamRNQTR6QThEUHRreVRsMmpJU29rMjFzcEVvbEl1VGRGaUt6WGtvdnotdFA4d05zN0c0ZTJ5ZFExNHd3WjlpRTlCbGtrNldIYjBFOA?oc=5","date":"2026-01-08","type":"earnings","source":"Finviz","summary":"Neogen (NASDAQ:NEOG) Beats Expectations in Strong Q4 CY2025, Stock Jumps 19.8% - Finviz","headline":"Neogen (NASDAQ:NEOG) Beats Expectations in Strong Q4 CY2025, Stock Jumps 19.8%","sentiment":"positive"},{"date":"2026-01-08","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-01-08","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQT2twWXh6T1FWeF9TaXkyVjQ3YVBkOGpxZnBKYXJuRmpQUnd4UHZ2dHdHcGpld0x5eEZOVUUxa1RVM25hbVlvQ0dkMUo1eTFmUkp3dDE4TlpkVEFWN0NObUFVT0VTdHo2WlVadXRPTDcwNUFuVmRlVlpWX09MTXJPanphazlIWUtaUXZMSjdSSG5Ud0JqSGtwZUxkY0VUN0ZTV3BlMFNiV1hhcklRRlE?oc=5","date":"2026-01-07","type":"pipeline","source":"Kalkine Media","summary":"Neogen Corporation (NASDAQ:NEOG) Nasdaq Composite Biosecurity Role - Kalkine Media","headline":"Neogen Corporation (NASDAQ:NEOG) Nasdaq Composite Biosecurity Role","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5JdlZZUnRQbVRJeVM3QTVYTTRUdU5scE1FekVIdjB4cUNDeTlsX2l3VkZkNkhQRFZCcEdUUVN6SGFDWC1aam9KajRRcU9tcnRLTHNKamp3?oc=5","date":"2025-12-16","type":"pipeline","source":"Gotrade","summary":"Neogen Corp. (NEOG) Stock Price Today & Analysis - Gotrade","headline":"Neogen Corp. (NEOG) Stock Price Today & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxNZ3J4cjNMV0xSMGltQjBuM2hHQ18xMUx4dnBjdzd3RXdidURVMnJRWTdmVDVRcUtnQ2lWYndRWmdBZUxSYUNXeEtsVVExVEp1UDh0Q0Z2cEo1eDkxODhRQjBZX1FlbHQ5Sjl0dFlrZlNCTHZCWEtxbDZEVEJLcThXVk5YMUpMWDNsTHd5N1Q0NGt0bVFIbHRmSEo2UWM0Q0w4MDM3UHVKTE5pVUVGWjNJdVg2eEFERk5Ub3dIdmxscy00WHAtRldRX3pFRmk3N1Myd1pXQ0FITGJ5WW1wUGZMNXljYllIRVBsWWZSdHRnclA4RVY2Zlk0d1IxSWRGYl9jRi1BbWttNEtwR1EyMXJmLVdwUE9XbWNSOV9WamtnZHhOUQ?oc=5","date":"2025-12-16","type":"pipeline","source":"PR Newswire","summary":"Investors who lost money with shares of Neogen Corporation (NASDAQ: NEOG) should contact the Shareholders Foundation in connection with Lawsuit - PR Newswire","headline":"Investors who lost money with shares of Neogen Corporation (NASDAQ: NEOG) should contact the Shareholders Foundation in ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPWVhPbzVreGJIenAzdDd2a2RvZ251a0JMbVdHaVZtdkVOckMyOTBXeXJEUUxSM2RQNkNRUHl1S09DU0JvWUF4MHZIZ2tmOFVSSHNuS29MbG4yOVpBdDVob3JmX2NSTUFpNjJhdkp1WXgxcmR6STktQUJuVG9CamZMNjVxUngteUZGT3ZzUF9hZVZPUkprRXlnTXJtNGdZMEp1THJDVzA2RjlLRmlrcWdBQl9Cbjhua0t0bGtCc2x1YXpFSDlpXzc2cnlXNjRBY0k2Mm5WbVZOVEFvdGR2NTloQU5vSjE?oc=5","date":"2025-12-09","type":"pipeline","source":"ACCESS Newswire","summary":"Neogen Corporation (NEOG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire","headline":"Neogen Corporation (NEOG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm ","sentiment":"neutral"},{"date":"2025-10-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOY1gteWwzbmlCYlNObU9lNTZ4MlZIRXFxaVlfSWQ3ZmE3MEIwaFJTaUJXMmpyTUZZYzR0OGYtcWtscndOM3Vzem55b1Q1b2NONjFja1MwZGF3STlNZ01sdnluMUJRenFEdjdxbkw5b2s2X1RyWHdEcWZHbWJrSWJxLUNvd1I?oc=5","date":"2025-09-24","type":"earnings","source":"Yahoo Finance","summary":"Neogen Corporation (NEOG) Slid Due to Below-Expected Revenue and Profitability - Yahoo Finance","headline":"Neogen Corporation (NEOG) Slid Due to Below-Expected Revenue and Profitability","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxQVlVzWTc0UV9WSVRnbEpLSG03Z1VMNHRmQWxkb0ROLWtXQTNjd3lDWDZSSlktVHgyeEJRMEpGRXR1R3NscWZZZThZZy1teEpRMTBDNUo2aFdRSjExYVFvWnRhenV2dERiVkxNVW5URF9sTXJOVTF0X0o1bjZXS3VqMEhuZjNfdWEydFdDbk5WcUJfVXo4V3MxbkNMcktablNrWVM5YlF3M1VPVHl2NDV5YXM5eU1FUTU3MzBPS3dhR1ByWHptRjJMS3JqZzRKd1F1QmJWcHRIakZqTl82cDNLV0dnWUozUktRNHZoSVREeU96RE5ndWV1a2JFSTVjcW9fa2NwTkh2aWVYVEVDbEFrN0o4SkphWUFOdDlsRHpOeUl6Unh1dVJfQWR6MzUzNjFLZzFVMnc1OWwxdHJsNmtyOVotWHdWbElkWG5uSW0tQmlIdlkyT3c?oc=5","date":"2025-07-22","type":"pipeline","source":"Business Wire","summary":"NEOG BREAKING NEWS: A Securities Fraud Class Action has been filed against Neogen Corporation -- Investors are Notified to Contact BFA Law to Potentially Recover Investment Losses - Business Wire","headline":"NEOG BREAKING NEWS: A Securities Fraud Class Action has been filed against Neogen Corporation -- Investors are Notified ","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["IDEXX Laboratories","Thermo Fisher Scientific","Bio-Rad Laboratories"],"therapeuticFocus":["Food Safety","Animal Safety"],"financials":{"source":"sec_edgar","revenue":894661000,"revenuePeriod":"2025-05-31","revenueHistory":[{"value":894661000,"period":"2025-05-31"},{"value":924222000,"period":"2024-05-31"},{"value":822447000,"period":"2023-05-31"},{"value":527159000,"period":"2022-05-31"},{"value":468459000,"period":"2021-05-31"},{"value":418170000,"period":"2020-05-31"}],"grossProfit":421376000,"grossProfitHistory":[],"rdSpend":21087000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-1092044000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":129004000,"cashHistory":[],"totalAssets":3443836000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":10.45,"previousClose":9.98,"fiftyTwoWeekHigh":11.43,"fiftyTwoWeekLow":3.87,"fiftyTwoWeekRange":"3.87 - 11.43","fiftyDayAverage":10.09,"twoHundredDayAverage":7.06,"beta":1.97,"enterpriseValue":2820640256,"forwardPE":32.3,"priceToBook":1.08,"priceToSales":2.58,"enterpriseToRevenue":3.2,"enterpriseToEbitda":31.21,"pegRatio":0,"ebitda":90364000,"ebitdaMargin":10.3,"freeCashflow":-924000,"operatingCashflow":66202000,"totalDebt":795070976,"debtToEquity":37.8,"currentRatio":3.91,"returnOnAssets":-0.5,"returnOnEquity":-25.3,"analystRating":"","recommendationKey":"none","numberOfAnalysts":3,"targetMeanPrice":11.67,"targetHighPrice":13,"targetLowPrice":10,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":0.9,"institutionHeldPercent":104.2,"sharesOutstanding":217525981,"floatShares":216357866,"sharesShort":9024290,"shortRatio":3.39,"shortPercentOfFloat":4.2,"epsTrailing":-2.78,"epsForward":0.32,"revenuePerShare":4.05,"bookValue":9.68,"officers":[{"age":null,"name":"Mr. Mikhael  Nassif","title":"CEO, President & Director"},{"age":55,"name":"Mr. R. Bryan Riggsbee CPA","title":"CFO & Senior Vice President"},{"age":null,"name":"Mr. John  Moylan","title":"VP, Corporate Controller & Chief Accounting Officer"},{"age":null,"name":"Dr. Jeremy  Yarwood","title":"Chief Scientific Officer"},{"age":null,"name":"Sarah  Demey","title":"Administrative Manager"},{"age":null,"name":"Mr. Bill  Waelke","title":"Head of Investor Relations"},{"age":56,"name":"Mr. Kevin M. Burke","title":"Chief Human Resources Officer"},{"age":null,"name":"Mr. Joe  Freels","title":"Senior VP & Chief Commercial Officer"}],"industry":"Medical Devices","irWebsite":"http://www.neogen.com/Corporate/invest.html","website":"https://www.neogen.com","phone":"517 372 9200"}}